|
Jul 2
|
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
|
|
Jun 30
|
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q1 Earnings Call
|
|
May 9
|
Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact
|
|
May 9
|
Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics
|
|
May 9
|
ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates
|
|
May 9
|
ANI: Q1 Earnings Snapshot
|
|
May 9
|
ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations
|
|
May 9
|
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
|
|
May 8
|
Pacira (PCRX) Q1 Earnings Surpass Estimates
|
|
May 8
|
Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow
|
|
May 5
|
ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?
|
|
May 5
|
ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
|
|
Feb 17
|
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?
|
|
Feb 17
|
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
|
|
Feb 17
|
Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?
|
|
Feb 14
|
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
|
|
Feb 13
|
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group
|
|
Jan 2
|
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
|
|
Jan 1
|
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
|
|
Dec 30
|
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|